Learn more

DEBREGEAS ET ASSOCIES PHARMA

Overview
  • Total Patents
    207
  • GoodIP Patent Rank
    54,703
  • Filing trend
    ⇩ 71.0%
About

DEBREGEAS ET ASSOCIES PHARMA has a total of 207 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2008. It filed its patents most often in France, WIPO (World Intellectual Property Organization) and Argentina. Its main competitors in its focus markets pharmaceuticals are CHENG NANZHENG, IROKO CARDIO LLC and HERMANN HOLGER LARS.

Patent filings per year

Chart showing DEBREGEAS ET ASSOCIES PHARMAs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

Top inventors

# Name Total Patents
#1 Suplie Pascal 164
#2 Lebon Christophe 127
#3 Paul David Olivier 19
#4 Vivet Philippe 18
#5 Lecoustey Sylvie 18
#6 Leboeuf Fabrice 18
#7 Jung Jennifer 18
#8 Deschamps Frantz 18
#9 Guiraud Julien 15
#10 Pascal Suplie 15

Latest patents

Publication Filing date Title
FR3049463A1 Unitary doses for immediate release of ghb or one of its therapeutically acceptable salts administered orally and use thereof to maintain alcoholic abstinence
TW201340994A A pharmaceutical composition appearing as a syrup of modafinil, its method for manufacturing and its application
WO2013128087A1 Process for obtaining a modafinil-based pharmaceutical composition, resulting pharmaceutical composition and use thereof
FR2987267A1 Application of modafinil in the treatment of substitution of cacanomanes
FR2971422A1 GAMMA-HYDROXYBUTYRIC ACID GRANULES
FR2963889A1 Nalbuphine-based formulations and uses thereof
CN102223879A Novel method for preparing granulates of active principles, and granulates obtained thereof
EP2349217A1 Granule of gamma-hydroxybutyric acid
WO2010055252A2 Plant-based granules
FR2949061A1 Floating microgranules
FR2949062A1 New pharmaceutical formulations against measuring medicines
FR2945748A1 Drug based on calcium and vitamin d.